CERO fundamentals
An in-depth look to CERo Therapeutics Holdings, Inc. operating, investing, and financing activities
CERO free cash flow for Q3 24 is -2.76 M USD. For 2023, CERO free cash flow was -1.52 M USD and operating cash flow was -1.52 M USD.
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM